Neoplasm Metastasis: all 3,564 studies

Page 11 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.

• Regorafenib and Nivolumab Simultaneous Combination TherapyCompletedNCT03406871Phase 1Results posted
• METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatinCompletedNCT03388190Phase 2Results posted
• Study of DS-8201a for Participants With Advanced Solid Malignant TumorsCompletedNCT03383692Phase 1Results posted
• E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)TerminatedNCT03332589Phase 1Results posted
• Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042CompletedNCT03307785Phase 1Results posted
• Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)CompletedNCT03299244Phase 3Results posted
• 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal MetastasesTerminatedNCT03275402Phase 2/3Results posted
• Pembrolizumab + Idelalisib for Lung Cancer StudyTerminatedNCT03257722Phase 1/2Results posted
• Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesCompletedNCT03256344Phase 1Results posted
• OsteoCool Tumor Ablation Post-Market StudyCompletedNCT03249584Not applicableResults posted
• Electronic Patient Reporting of Symptoms During Cancer TreatmentCompletedNCT03249090Not applicableResults posted
• A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)TerminatedNCT03248492Phase 2Results posted
• PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT03218826Phase 1Results posted
• Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesActive, not recruitingNCT03217747Phase 1/2Results posted
• RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid TumoursCompletedNCT03199872Phase 1/2Results posted
• T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic RadiosurgeryTerminatedNCT03190967Phase 1/2Results posted
• Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain MetastasesTerminatedNCT03189381Not applicableResults posted
• A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have SpreadTerminatedNCT03166631Phase 1Results posted
• MAGE-A4ᶜ¹º³²T for Multi-TumorActive, not recruitingNCT03132922Phase 1Results posted
• AFPᶜ³³²T in Advanced HCCCompletedNCT03132792Phase 1Results posted
• QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesCompletedNCT03126110Phase 1/2Results posted
• Study of Topical SOR007 Ointment for Cutaneous MetastasesCompletedNCT03101358Phase 1/2Results posted
• Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate CancerCompletedNCT03098836Phase 2Results posted
• A Pilot Study of Oxalate Absorption in Secondary HyperoxaluriaCompletedNCT03095885Not applicableResults posted
• A Study of AK-01 (LY3295668) in Solid TumorsCompletedNCT03092934Phase 1/2Results posted
• Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian CancerCompletedNCT03085238Not applicableResults posted
• Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaCompletedNCT03082534Phase 2Results posted
• Lazanda in Cancer Patients Receiving Palliative RadiationTerminatedNCT03071744Phase 2Results posted
• Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell CarcinomaActive, not recruitingNCT03071406Phase 2Results posted
• A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced SarcomaActive, not recruitingNCT03069378Phase 2Results posted
• Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid TumorsActive, not recruitingNCT03035409Phase 2Results posted
• An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.TerminatedNCT03029988Phase 1Results posted
• Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent CancerActive, not recruitingNCT03021486Phase 2/3Results posted
• Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable CancerTerminatedNCT03009058Phase 1/2Results posted
• CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast CancerCompletedNCT02992067Results posted
• Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain MetastasesTerminatedNCT02974803Phase 2Results posted
• Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerCompletedNCT02964078Phase 2Results posted
• Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)TerminatedNCT02959437Phase 1/2Results posted
• Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and SafetyCompletedNCT02953938Phase 4Results posted
• Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast CancerCompletedNCT02948751Results posted
• A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT02923349Phase 1/2Results posted
• A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic CancersCompletedNCT02919696Phase 1Results posted
• Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung CancerCompletedNCT02916745Phase 1Results posted
• A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and CapecitabineCompletedNCT02915744Phase 3Results posted
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsCompletedNCT02903914Phase 1Results posted
• SIMT Stereotactic Radiosurgery Outcomes StudyCompletedNCT02886572Not applicableResults posted
• Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic DiseaseCompletedNCT02843165Phase 2Results posted
• A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving HaemodialysisCompletedNCT02833857Phase 1Results posted
• Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney CancerTerminatedNCT02795819Phase 1Results posted
• A Study to Collect Data About Analgesia in Patients With Bone MetastasisCompletedNCT02774213Results posted
• Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasesTerminatedNCT02758132Phase 2Results posted
• Standard of Care Chemotherapy Plus Pembrolizumab for Breast CancerActive, not recruitingNCT02734290Phase 1/2Results posted
• Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticActive, not recruitingNCT02721732Phase 2Results posted
• Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal MetastasesTerminatedNCT02715856Not applicableResults posted
• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract CancerActive, not recruitingNCT02711553Phase 2Results posted
• A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid TumorsCompletedNCT02697591Phase 1/2Results posted
• Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's PhenomenonCompletedNCT02688270Phase 2Results posted
• A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyCompletedNCT02688088Phase 1Results posted
• A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With CancerCompletedNCT02677116Phase 1Results posted
• A Study of Durvalumab (MEDI4736) and Monalizumab in Solid TumorsActive, not recruitingNCT02671435Phase 1/2Results posted
• Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal MetastasesCompletedNCT02616393Phase 2Results posted
• Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid TherapyCompletedNCT02609828Phase 3Results posted
• Secondary Prevention of Cardiovascular Disease in the Elderly TrialCompletedNCT02596126Phase 3Results posted
• Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone MetastasesTerminatedNCT02582749Phase 2Results posted
• Treatment of Brain Metastases From Breast Cancer With Eribulin MesylateCompletedNCT02581839Phase 2Results posted
• Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms TumorsTerminatedNCT02581384Phase 1/2Results posted
• Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerCompletedNCT02536742Phase 2Results posted
• A Study of LY3076226 in Participants With Advanced or Metastatic CancerCompletedNCT02529553Phase 1Results posted
• Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated OsteosarcomaCompletedNCT02517918Phase 1Results posted
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid TumorsCompletedNCT02517398Phase 1Results posted
• Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal MetastasesCompletedNCT02512965Not applicableResults posted
• Multicenter Study of Cryoablation for Palliation of Painful Bone MetastasesCompletedNCT02511678Not applicableResults posted
• Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver MetastasesCompletedNCT02511522Not applicableResults posted
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerCompletedNCT02492711Phase 3Results posted
• Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced CancerActive, not recruitingNCT02491632Phase 2/3Results posted
• Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain MetastasesTerminatedNCT02490878Phase 2Results posted
• Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic DiseaseTerminatedNCT02469701Phase 2Results posted
• Irreversible Electroporation Ablation for Colorectal Metastases to the LungCompletedNCT02461550Not applicableResults posted
• Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)TerminatedNCT02460874Phase 1/2Results posted
• Study Evaluating the Biologic Activity of Guanabenz in Bone MetastasisTerminatedNCT02443103Not applicableResults posted
• BG00012 and Delay of Disability Progression in Secondary Progressive Multiple SclerosisTerminatedNCT02430532Phase 3Results posted
• A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02411591Phase 1Results posted
• Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTerminatedNCT02408861Phase 1Results posted
• Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic CancerTerminatedNCT02376933Not applicableResults posted
• Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase IICompletedNCT02352259Phase 2Results posted
• Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedNCT02341417Phase 3Results posted
• Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal MetastasesCompletedNCT02320825Phase 3Results posted
• A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLCCompletedNCT02314364Phase 2Results posted
• Radium-223 Dichloride Long-term Follow-up ProgramCompletedNCT02312960Phase 4Results posted
• A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainCompletedNCT02308020Phase 2Results posted
• RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic CancersCompletedNCT02303990Phase 1Results posted
• Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)CompletedNCT02301364Phase 2Results posted
• A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]CompletedNCT02297438Phase 3Results posted
• Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple SclerosisTerminatedNCT02296346Not applicableResults posted
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?CompletedNCT02286843Not applicableResults posted
• BrUOG L301 With Non-Small Cell Lung Cancer and Bone MetastasesCompletedNCT02283749Phase 2Results posted
• Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002CompletedNCT02282813Phase 3Results posted
• A Study of LY3022855 In Participants With Breast or Prostate CancerCompletedNCT02265536Phase 1Results posted

← Neoplasm Metastasis overview